¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"plating colony count technique"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • sectored colony
    ºÎä²ÃºÐÇÒÁý¶ô
  • single colony isolation
    ´ÜÀÏÁý¶ôºÐ¸®, Áý¶ô°í¸£±â
  • smooth colony
    ¸Å²öÁý¶ô, ÆòȰÁý¶ô
  • aseptic technique
    ¹«±Õ±â¼ú
  • adjunctive imaging technique
    º¸Á¶¿µ»ó±â¹ý
  • afterloading technique
    ÈÄÀåÁø¹ý
  • analytical technique
    ºÐ¼®±â¹ý
  • boost technique
    Ãß°¡Ä¡·á±â¹ý
  • broadband transmission technique
    ±¤ÆøÁ֯ļöÀüÆÄ±â¼ú
  • coaxial technique
    µ¿Ãà±â¹ý
  • column extraction technique
    Ä®·³ÃßÃâ±â¹ý
  • cone down technique
    Á¶»ç¿µ¿ªÃà¼Ò¹ý
  • cross fire technique
    ½ÊÀÚÆ÷È­Á¶»ç¹ý
  • cross-finger technique
    ¼Õ°¡¶ô±³Â÷¹ý, ¼öÁö±³Â÷¹ý
  • cumulative sum technique
    ´©ÀûÇÕ»ê¼ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • giant colony
    °Å´ëÁý¶ô
  • glossy colony
    ±¤ÅÃÁý¶ô
  • hybridization colony
    Áý¶ôºÎÇÕÈ­
  • mucoid colony
    Á¡¾×Áý¶ô
  • rough colony
    °ÅÄ£Áý¶ô
  • sectored colony
    ºÎä²ÃºÐÇÒÁý¶ô
  • smooth colony
    ¸Å²öÁý¶ô
  • spheroid colony
    °ø¸ð¾çÁý¶ô
  • spidery colony
    °Å¹ÌÁÙÁý¶ô
  • granulocyte colony-stimulating factor
    °ú¸³±¸Áý¶ôÀÚ±ØÀÎÀÚ
  • granulocyte-macrophage colony-stimulating factor
    °ú¸³±¸Å«Æ÷½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ
  • macrophage colony-stimulating factor
    Å«Æ÷½Ä¼¼Æ÷Áý¶ôÀÚ±ØÀÎÀÚ
  • single colony isolation
    ´ÜÀÏÁý¶ôºÐ¸®, Áý¶ô°í¸£±â
  • adjunctive imaging technique
    º¸Á¶¿µ»ó±â¹ý
  • afterloading technique
    ÈÄÀåÁø¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • analysis of variance technique
    ºÐ»ê±â¼úºÐ¼®
  • analytical technique
    ºÐ¼®±â¼ú
  • arterial puncture technique
    µ¿¸ÆÃµÀÚ¼ö±â<--±â¼ú>
  • aseptic technique
    ¹«±Õ¼ú.
  • frequency selective fat suppression technique
    Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦(±â)¹ý
  • full bladder technique
    ¹æ±¤ Ãæ¸¸¹ý
  • imagery technique
    »ó»ó ±â¹ý
  • immunoenzyme technique
    ¸é¿ªÈ¿¼Ò¹ý
  • immunoferritin technique
    ¸é¿ªÆä¸®Æ¾¹ý
  • immunologic technique
    ¸é¿ªÇÐÀû±â¼ú
  • implant button technique
    ÀΰøÄ¡½ÄÄ¡¼ú(ìÑÍïöÍãÕöÍâú).
  • indirect fluorescent antibody technique
    °£Á¢Çü±¤Ç×ü¹ý
  • ingram technique
    Àα׶÷ ¹ý
  • inplant button technique
    ÀΰøÄ¡½ÄÄ¡¼ú.
  • plaque technique
    ÇöóÅ© °Ë»ç±â¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • radioactivity count
    ¹æ»ç´ÉÃøÁ¤
  • reticulocyte count
    ¸Á(»ó)ÀûÇ÷±¸»êÁ¤(ØÑßÒîåúìϹߩïÒ).
  • reticulocyte count
    ¸Á(»ó)ÀûÇ÷±¸»êÁ¤(ØÑßÒîåúìϹߩïÒ)
  • telogen count
    ÈÞÁö±â ¸ð¹ß°è¼ö
  • total bacterial count
    Ãѱռö
  • total count of bacteria
    Ãѱռö°èÃø(õÅж⦠ͪö°).
  • viable count of bacteria
    »ý±Õ¼ö°èÃø(ßæÐ¶â¦Íªö´).
  • white blood (cell) count =WBC
    ¹éÇ÷±¸¼ö(ÛÜúìϹâ¦).
  • bacterial colony
    ¼¼±ÕÁý¶ô(¡­ó¢Õª).
  • colony
    Áý¶ô(ó¢Õª) ¡ì¼¼±ÕÀÇ¡í, ±ºÃ¼(ÏØô÷) ¡ìµ¿¹°ÀÇ¡í, ÄݷδÏ.
  • colony
    Áý¶ô
  • colony
    Áý¶ô(ó¢Õª) ¡ì¼¼±ÕÀÇ¡í, ±ºÃ¼(ÏØô÷) ¡ìµ¿¹°ÀÇ¡í, ÄݷδÏ.
  • colony counter
    Áý¶ô°è»ê±â(¡­Íªß©Ðï), Áý¶ô°è¼ö±â.
  • colony counter
    Áý¶ô°è»ê±â(¡­Íªß©Ðï), Áý¶ô°è¼ö±â.
  • colony formation assay
    Áý¶ôÇü¼º´ÉÃøÁ¤
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • microdrop technique
    ¹Ì¼¼ÀûÁ¤¼ú(Ú°á¬îêïÒâú)
  • neutron contrast matching technique
    Áß¼ºÀÚ Á¶¿µ´ëÀÀ¼ú(ñéàõí­ðÎç¯Óßëëâú)
  • Oudin technique
    ¿ìµò ¼ú(âú)
  • overspeeding technique
    °ú¼Ó¼ú(ΦáÜâú)
  • plaque technique
    ÇöóÅ©¼ú(âú)
  • rapid flow technique
    ±Þ·ù¼ú(Ðá×µâú)
  • rapid mixing technique
    ±ÞÈ¥ÇÕ¼ú(Ðáûèùêâú)
  • recombinant DNA technique
    ÀçÁ¶ÇÕ(î¢ðÚùê) DNA ¼ú(âú)
  • recombinant RNA technique
    ÀçÁ¶ÇÕ(î¢ðÚùê) RNA ¼ú(âú)
  • relaxation technique
    ÀÌ¿Ï ¼ú(ì¬èÐâú)
  • ribosome binding technique
    ¶óÀ̺¸¼Ø °áÇÕ¼ú(Ì¿ùêâú)
  • rosette technique
    ·ÎÁ¦Æ®¼ú(âú)
  • rotation technique
    ȸÀü¼ú(üÞï®âú)
  • slice technique
    ¹ÚÆí¼ú(ÚÝø¸âú)
  • SRS technique
    SRS ¼ú±â(âúÐü)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • simulated echo technique
    ¸ðÀÇ¿¡ÄÚ±â¹ý
  • single pass technique
    ´ÜÀÏÅë°ú±â¹ý
  • single-shot technique
    ´Ü¹ßÆ÷±â¹ý
  • soft tissue technique
    ¿¬Á¶Á÷±â¹ý
  • spin echo technique
    ½ºÇÉ¿¡ÄÚ±â¹ý
  • sterile technique
    ¹«±Õ¼ú, ¹«±Õ¹ý
  • technic; technique
    ±â¼ú, ¹ý, (¹æ)½Ä
  • technique
    ¼ö±â, ±â¼ú
  • transfontanelle technique
    °æÃµ¹®±â¹ý
  • ultrasonic technique
    ÃÊÀ½ÆÄ±â¹ý
  • variable bandwidth technique
    ´Ùº¯Á֯ļöÆø±â¹ý
  • volume gradient echo technique
    ¿ëÀû°æ»ç¿¡ÄÚ±â¹ý
  • water bath technique
    ¼öÁ¶½Ä±â¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CC&C colony count and culture
CF calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ...
CFC capillary filtration coefficient; colony-forming capacity; cardiofaciocutaneous [syndrome]; chlorofl...
CFU-S, CFUS colony-forming unit, spleen; colony-forming unit, stem cells
ODT Occlusive Dressing Technique; ¹ÐºÀ ¿ä¹ý
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
IFAT In direct Fluorescent Antibody Technique
MCT Modified Clinical Technique
MIGET Multiple Inert Gas Elimination Technique
PAP Peroxidase-antiperoxidase technique
Rusitec Rumen Simulation Technique
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • collection technique
    äÃë¹ý
  • crevicular brushing technique
    ¿­±¸³» Ä¡¼ÖÁú¹ý
  • cross fire technique
    ½ÊÀÚÆ÷È­ Á¶»ç¹ý
  • cryoneuroablative technique
    µ¿°á ½Å°æ ÀýÁ¦¼ú
  • cumulative sum technique
    ´©Àû ÇÕ»ê ¼ú½Ä
  • cytochemical technique
    ¼¼Æ÷ È­ÇÐÀû ±â¼ú
  • distraction technique for the cervicospinal area
    °æÃߺΠ½ÅÀü¼ú
  • diurnal electronic measuring technique
    ÁÖ°£ ÀüÀÚ ÃøÁ¤¹ý
  • double exposure technique
    Áߺ¹ X¼± ÃÔ¿µ¼ú
  • double layer fluorescent antibody technique
    ÀÌÃþ Çü±¤ Ç×ü¹ý
  • electron probe microanalysis technique
    ÀüÀÚ Å½Ä§ ¹Ì¼¼ ºÐ¼®¹ý
  • expansion investing technique
    ÆØÃ¢ ¸Å¸ô¹ý
    ¸Å¸ô ½Ã, ³³ÇüÀÇ ¿­ÆØÃ¢ ¶Ç´Â ¸Å¸ôÀçÀÇ ¿­ÆØÃ¢, °æÈ­ ÆØÃ¢À» ÀÌ¿ëÇÏ¿© ³³ÇüÀÇ ¹æ³Ã ¼öÃà ¹× ±Ý¼ÓÀÇ ÁÖÁ¶ ¼öÃ൵ µÉ ¼ö Àִ´ë·Î º¸»óÇÏ¿© ¿Íµ¿¿¡ Á¤¹ÐÇÏ°Ô ÀûÇÕÇÏ´Â Àη¹ÀÌ µî º¸Ã¶¹°À» Á¦ÀÛÇÏ·Á°í ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • extraction technique
    ÃßÃâ¹ý
  • extraoral radiographic technique
    ±¸¿Ü ÃÔ¿µ¼ú
  • fingerprinting technique
    Áö¹®¼ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
absolute CD4 count The number of helper T-lymphocytes in a cubic millimeter of blood. With HIV, the absolute CD4 count declines as the infection progresses. The absolute CD4 count is frequently used to monitor the extent of immune suppression in persons with HIV. Also called a T4 count.
(12 Dec 1998)
absolute eosinophil count <haematology, investigation> A measurement (cells per microlitre) of the number of eosinophils in a blood specimen.
This measurement is useful in the evaluation of autoimmune disease, allergies, eczema, leukaemia, asthma and hay fever. Normal absolute eosinophil counts are less than 350 cells/mcl (microlitre).
(27 Sep 1997)
Addis count A quantitative enumeration of the red blood count, white blood count, and casts in a 12-hr urine specimen; used to follow the progress of known renal disease.
(05 Mar 2000)
Arneth count The percentage distribution of polymorphonuclear neutrophils, based on the number of lobes in the nuclei (from 1 to 5).
See: Arneth index.
(05 Mar 2000)
b and t cell count A test that measures the respective quantities of B lymphocytes and T lymphocytes. This test is often performed in the analysis of an immune deficiency disorder. Normal values include: 68 to 75% of total lymphocytes are T lymphocytes and 10 to 20% are B lymphocytes.
Increased T-cell counts can indicate infectious mononucleosis, acute lymphocytic leukaemia or multiple myeloma.
Increased B lymphocytes can indicate chronic lymphocytic leukaemia, multiple myeloma, Waldenstrom's macroglobulinaemia or Di George syndrome. Decreased T-cells may indicate congenital T-cell deficiency, Wiskott-Aldrich syndrome or AIDS. Decreased B-cells may indicate acute lymphocytic leukaemia or a congenital immunoglobulin deficiency disorder.
(27 Sep 1997)
blood cell count A count of the number of leukocytes and erythrocytes per unit volume in a sample of venous blood. A complete blood count (cbc) also includes measurement of the haemoglobin, haematocrit, and erythrocyte indices.
(12 Dec 1998)
blood count <haematology, investigation> The determination of the proper number of red blood cells, white blood cells and platelets are present in the patients blood.
Acronym: FBC
(16 Dec 1997)
red blood cell count A normal value is 4.6-6.2 million RBC's per cubic millimetre of blood. This number can increase in cases of dehydration (fluid loss) or severe lung disease. Interestingly, red blood cell counts are much higher in those who live at high altitude, because of the increased demand for oxygen carrying capacity.
(27 Sep 1997)
viable cell count Number of cells in a given area or volume that are thriving.
(05 Mar 2000)
viable count Measurement of the concentration of live cells in a microbial population.
(09 Oct 1997)
CD4/CD8 count The ratio of the number of helper-inducer T lymphocytes to cytotoxic-suppressor T lymphocytes, as measured by monoclonal antibodies to the CD4 surface antigen found on helper-inducer T-cells, and the CD8 surface antigen found on cytotoxic-suppressor T-cells. In healthy individuals, the H/S ratio ranges between 1.6 and 2.2.When the body mounts an immune response, as against a virus or a transplant, the ratio is almost always reduced because of a decrease in the number of circulating helper-inducer cells and an increase in suppressor cells. The CD4/CD8 count has been used to monitor for signs of organ rejection after transplants, and more recently has become a tool for assessing the relative condition of HIV patients. With the CD4 absolute count and the CD4 lymphocyte percentage, it provides a way of gauging the progression from HIV to AIDS.
(05 Mar 2000)
CD4 cell count The most commonly used surrogate marker for assessing the state of the immune system. As CD4 cell count declines, the risk of developing opportunistic infections increases. The normal range for CD4 cell counts is 500 to 1500 per cubic millimetre of blood. CD4 count should be rechecked at least every six to twelve months if CD4s are greater than 500/mm3. If the count is lower, testing every three months is advised.
(09 Oct 1997)
CD4 count, absolute The number of helper T-lymphocytes in a cubic millimeter of blood. With HIV, the absolute CD4 count declines as the infection progresses. The absolute CD4 count is frequently used to monitor the extent of immune suppression in persons with HIV. Also called a T4 count.
(12 Dec 1998)
CD4 lymphocyte count A count of the number of CD4-positive lymphocytes in the blood. Determination requires the use of a fluorescence-activated flow cytometer.
(12 Dec 1998)
cell count A count of the number of cells of a specific kind, usually measured per unit volume of sample.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á